Takeda Pharmaceutical Co. Ltd. · TSE:4502
Furuta Milano received 7,800 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)
Traded Apr 27, 2026 · Filed Apr 28, 2026
On Apr 27, 2026, Furuta Milano (Director, Chief Financial Officer) received 7,800 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 57,900 shares. Filed Apr 28, 2026 (Form 4).
- Awarded
- 7,800 shares
- Holding after
- 57,900 shares
- Trading plan
- No
- Role
- Director, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Ordinary Shares | Award | 7,800 | 57,900 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Furuta Milano
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Furuta Milano · Jul 6, 2026
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026